诺和诺德(NVO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NVO 诺和诺德

盘前交易 07-23 07:42:48 EDT

66.78

+1.86

+2.87%

盘前68.38

+1.60+2.40%

07:41 EDT

最高66.97	最低65.45	成交量897.02万
今开65.52	昨收64.92	日振幅2.34%
总市值2,964亿	流通市值2,126亿	总股本44.39亿
成交额5.96亿	换手率0.28%	流通股本31.84亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"NVO","market":"US","secType":"STK","nameCN":"诺和诺德","latestPrice":66.78,"timestamp":1753214400000,"preClose":64.92,"halted":0,"volume":8970239,"hourTrading":{"tag":"盘前","latestPrice":68.38,"preClose":66.78,"latestTime":"07:41 EDT","volume":70752,"amount":4853065.75776,"timestamp":1753270871111},"delay":0,"floatShares":3183545765,"shares":4439052849,"eps":3.401716,"marketStatus":"盘前交易","change":1.86,"latestTime":"07-23 07:42:48 EDT","open":65.52,"high":66.97,"low":65.45,"amount":596073861.639435,"amplitude":0.023413,"askPrice":68.42,"askSize":640,"bidPrice":68.39,"bidSize":800,"shortable":3,"etf":0,"ttmEps":3.401716,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753277400000},"marketStatusCode":1,"adr":1,"adrRate":1,"listingDate":363499200000,"exchange":"NYSE","adjPreClose":66.78,"dividendRate":0.023959,"preHourTrading":{"tag":"盘前","latestPrice":68.38,"preClose":66.78,"latestTime":"07:41 EDT","volume":70752,"amount":4853065.75776,"timestamp":1753270871111},"postHourTrading":{"tag":"盘后","latestPrice":66.6807,"preClose":66.78,"latestTime":"19:59 EDT","volume":61158,"amount":4086641.6713,"timestamp":1753228779073},"volumeRatio":1.173021040936923,"impliedVol":0.4704,"impliedVolPercentile":0.51},"requestUrl":"/m/hq/s/NVO","defaultTab":"news","newsList":[{"id":"2553229681","title":"诺和诺德7月22日成交额为5.97亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553229681","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553229681?lang=zh_cn&edition=full","pubTime":"2025-07-23 12:32","pubTimestamp":1753245132,"startTime":"0","endTime":"0","summary":"美东时间2025年7月22日，诺和诺德成交额为5.97亿美元，成交额较昨日增加11.40%，当日成交量为897.03万股。诺和诺德于2025年7月22日涨2.87%，报66.78美元，该股过去5个交易日跌0.65%，年初至今跌21.32%，过去60日涨6.63%。诺和诺德还有一个生物制药部门，专门从事血友病和其他疾病的蛋白质疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723123215a6bc6a8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723123215a6bc6a8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BZ1G4Q59.USD","BK4588","LU0154236417.USD","IE00BKVL7J92.USD","LU1093756325.SGD","LU1093756168.USD","BK4599","BK4532","BK4007","BK4585","NVO"],"gpt_icon":1},{"id":"2553289268","title":"诺和诺德7月21日成交额为5.36亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553289268","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553289268?lang=zh_cn&edition=full","pubTime":"2025-07-22 12:28","pubTimestamp":1753158497,"startTime":"0","endTime":"0","summary":"美东时间2025年7月21日，诺和诺德成交额为5.36亿美元，成交额较昨日增加3.05%，当日成交量为828.07万股。诺和诺德于2025年7月21日涨0.95%，报64.92美元，该股过去5个交易日跌5.83%，年初至今跌23.51%，过去60日涨5.91%。诺和诺德还有一个生物制药部门，专门从事血友病和其他疾病的蛋白质疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722122824a6b9c494&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722122824a6b9c494&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1093756325.SGD","IE00BKVL7J92.USD","BK4585","IE00BZ1G4Q59.USD","LU1093756168.USD","NVO","BK4007","BK4599","LU0154236417.USD","BK4588","BK4532"],"gpt_icon":1},{"id":"2553289303","title":"联邦制药涨超8%机构指UBT251具备GLP-1药物减重效果BIC潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=2553289303","media":"动脉网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553289303?lang=zh_cn&edition=full","pubTime":"2025-07-22 11:54","pubTimestamp":1753156440,"startTime":"0","endTime":"0","summary":"联邦制药涨超8%，因UBT251具备减重效果BIC潜力，与诺和诺德达成独家许可协议，机构看好其药物价值兑现。公司还拟配售新股筹资用于扩充生产及研发。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072212052397aff03a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072212052397aff03a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVO","BK1191","03933"],"gpt_icon":0},{"id":"2552415162","title":"丹麦减肥药热潮下，丹麦零售业面临新一轮冲击","url":"https://stock-news.laohu8.com/highlight/detail?id=2552415162","media":"环球网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552415162?lang=zh_cn&edition=full","pubTime":"2025-07-19 10:17","pubTimestamp":1752891443,"startTime":"0","endTime":"0","summary":"当地时间7月18日，丹麦零售商行业协会发布分析报告指出，以诺和诺德旗下Wegovy为代表的减肥药普及，可能导致丹麦杂货店年度销售额损失6亿至12亿丹麦克朗，相当于行业总营收的0.65%。DSK数据显示，丹麦潜在长期减重药使用者达46.5万人。分析指出，若未来减重药以口服形式上市且价格下降，使用者规模可能进一步扩大。部分丹麦中小企业报告因诺和诺德“抢人”面临劳动力短缺，而减重药对零售业的冲击更凸显其经济影响的复杂性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250719101813a45494ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250719101813a45494ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVO"],"gpt_icon":1},{"id":"2552311461","title":"诺和诺德寸步不让","url":"https://stock-news.laohu8.com/highlight/detail?id=2552311461","media":"生物制品圈","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552311461?lang=zh_cn&edition=full","pubTime":"2025-07-18 17:34","pubTimestamp":1752831255,"startTime":"0","endTime":"0","summary":"诺和诺德多维进击，寸步不让，持续加码代谢领域。7月8日，诺和诺德向欧洲药品管理局提交的7.2mg司美格鲁肽上市申请获得受理。诺和诺德凭借其前瞻性布局，在GLP-1/Amylin双靶点减重疗法领域取得全球领先地位。诺和诺德计划于2026年第一季度启动其减重III期临床试验。2020年6月，诺和诺德以21亿美元收购Corvidia Therapeutics，获得长效抗IL-6抗体Ziltivekimab。2022年9月，诺和诺德以潜在总价7亿美元引进Ventus Therapeutics的口服NLRP3抑制剂NNC6022-0001。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718182245a453492b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718182245a453492b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1093756168.USD","IE00BKVL7J92.USD","LU0154236417.USD","BK4585","NVO","BK4588","BK4007","LU1093756325.SGD","BK4532","BK4599","IE00BZ1G4Q59.USD"],"gpt_icon":1},{"id":"2552465966","title":"刚刚！诺和诺德“司美格鲁肽注射液”新适应症国内获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2552465966","media":"Insight数据库","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552465966?lang=zh_cn&edition=full","pubTime":"2025-07-18 16:13","pubTimestamp":1752826408,"startTime":"0","endTime":"0","summary":"7 月 17 日，NMPA 官网显示，诺和诺德司美格鲁肽注射液的获批一项新适应症。根据公开资料和临床试验进展，Insight 数据库推测，本次获批新适应症可能为：成人 2 型糖尿病合并慢性肾脏疾病。安全性方面，司美格鲁肽组报告的严重不良事件数量少于安慰剂组。随着新适应症的不断拓展，司美格鲁肽的销售额无疑将得到进一步的放量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718164641a6b1b115&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718164641a6b1b115&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4532","BK4599","BK4585","BK4007","IE00BZ1G4Q59.USD","NVO","LU0154236417.USD","LU1093756168.USD","BK4588","LU1093756325.SGD","IE00BKVL7J92.USD"],"gpt_icon":1},{"id":"2552594504","title":"诺和诺德7月17日成交额为5.93亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552594504","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552594504?lang=zh_cn&edition=full","pubTime":"2025-07-18 12:24","pubTimestamp":1752812658,"startTime":"0","endTime":"0","summary":"美东时间2025年7月17日，诺和诺德成交额为5.93亿美元，成交额较昨日增加56.97%，当日成交量为904.18万股。诺和诺德于2025年7月17日跌2.61%，报65.29美元，该股过去5个交易日跌8.06%，年初至今跌23.08%，过去60日涨11.93%。诺和诺德还有一个生物制药部门，专门从事血友病和其他疾病的蛋白质疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718122424a4528590&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718122424a4528590&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","IE00BKVL7J92.USD","LU0154236417.USD","NVO","BK4532","BK4599","BK4585","BK4007","LU1093756168.USD","LU1093756325.SGD","IE00BZ1G4Q59.USD"],"gpt_icon":1},{"id":"2552482201","title":"美国OTC市场Novo Nordisk A/S盘中异动 早盘股价大跌3.51%报66.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552482201","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552482201?lang=zh_cn&edition=full","pubTime":"2025-07-17 22:11","pubTimestamp":1752761494,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日22时11分，美国OTC市场Novo Nordisk A/S股票出现异动，股价急速跳水3.51%。截至发稿，该股报66.00美元/股，成交量82股，换手率0.00%，振幅1.18%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。美国OTC市场Novo Nordisk A/S股票所在的制药行业中，整体跌幅为0.57%。美国OTC市场Novo Nordisk A/S公司简介：诺和诺德拥有全球约三分之一的品牌糖尿病治疗市场，是全球领先的糖尿病护理产品供应商。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071722113497a9df28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071722113497a9df28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BKVL7J92.USD","LU1093756168.USD","NVO","BK4599","LU1093756325.SGD","BK4585","LU0154236417.USD","IE00BZ1G4Q59.USD","NONOF","BK4532","BK4588","BK4007"],"gpt_icon":1},{"id":"2551914257","title":"诺和诺德三度亮相链博会，共筑医药行业可持续发展新生态","url":"https://stock-news.laohu8.com/highlight/detail?id=2551914257","media":"环球网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551914257?lang=zh_cn&edition=full","pubTime":"2025-07-16 17:52","pubTimestamp":1752659532,"startTime":"0","endTime":"0","summary":"全球领先的生物制药公司诺和诺德连续第三年参展链博会，延续“驱动改变，健康中国”主题，全方位展示公司在华的全产业链战略布局；还将出席“可持续市场倡议”中国论坛，共谋共建行业高质量可持续发展。主办方供图本届链博会，诺和诺德将在425平米的展台上，从“链接全球创新”，“链启慢病管理”，“共筑健康中国”等方面展示其植根中国 30 余年的成果。在本届链博会上，诺和诺德与多家本土合作伙伴宣布新的合作关系。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716175521a44e71a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716175521a44e71a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1093756168.USD","BK4599","BK4532","BK4588","LU0154236417.USD","IE00BZ1G4Q59.USD","NVO","IE00BKVL7J92.USD","LU1093756325.SGD","BK4007","BK4585"],"gpt_icon":1},{"id":"2551211437","title":"诺和诺德7月15日成交额为4.90亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551211437","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551211437?lang=zh_cn&edition=full","pubTime":"2025-07-16 12:32","pubTimestamp":1752640332,"startTime":"0","endTime":"0","summary":"美东时间2025年7月15日，诺和诺德成交额为4.90亿美元，成交额较昨日增加18.15%，当日成交量为725.08万股。诺和诺德于2025年7月15日跌2.49%，报67.22美元，该股过去5个交易日跌3.48%，年初至今跌20.8%，过去60日涨6.9%。诺和诺德还有一个生物制药部门，专门从事血友病和其他疾病的蛋白质疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716123214a6ac8e88&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716123214a6ac8e88&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LU0154236417.USD","BK4588","LU1093756325.SGD","BK4599","BK4585","BK4532","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","NVO","LU1093756168.USD"],"gpt_icon":1},{"id":"2551611344","title":"国产新减肥药上市，赛道竞争加剧！","url":"https://stock-news.laohu8.com/highlight/detail?id=2551611344","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551611344?lang=zh_cn&edition=full","pubTime":"2025-07-16 09:26","pubTimestamp":1752629185,"startTime":"0","endTime":"0","summary":"此前的6月27日，国家药品监督管理局批准了玛仕度肽注射液上市，其适应症明确为成人肥胖或超重患者的长期体重控制。业内人士认为，玛仕度肽的上市不仅为有减重需求的人群提供了新的选择，更重要的是，它将进一步加速行业内的研发竞争。未来，随着更多创新药物的研发和上市，减肥药市场的竞争格局还将不断发生变化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071609271297a7c411&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071609271297a7c411&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2211815571.USD","LU0203202063.USD","LU0823416689.USD","LU0256863811.USD","SG9999001176.USD","LU2264538146.SGD","BK4581","LU0096364046.USD","LU2265009873.SGD","LU0456855351.SGD","LU1366192091.USD","01801","LU0672654240.SGD","SG9999018857.SGD","LLY","LU0106261372.USD","LU2417539215.USD","LU1035775433.USD","LU2063271972.USD","LU1868836591.USD","LU0820561818.USD","LU1868836757.USD","LU1623119135.USD","SG9999017495.SGD","BK4534","LU2236285917.USD","LU2237443549.SGD","LU1720051108.HKD","LU1983299246.USD","BK4588","LU1057294990.SGD","SG9999015986.USD","LU1069344957.HKD","LU1280957306.USD","LU1868837300.USD","LU2106854487.HKD","LU0122379950.USD","SGXZ51526630.SGD","LU2461242641.AUD","600276","IE00B2B36J28.USD","LU0708995401.HKD","NVO","LU1127390331.HKD","LU2112291526.USD","LU0256863902.USD","LU2361044949.HKD","LU2491050154.USD","LU0203201768.USD","LU1093756325.SGD","IE00B4R5TH58.HKD","SG9999013999.USD","LU2456880835.USD"],"gpt_icon":1},{"id":"2551902631","title":"GLP-1这次真的“卷到头了”","url":"https://stock-news.laohu8.com/highlight/detail?id=2551902631","media":"药渡","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551902631?lang=zh_cn&edition=full","pubTime":"2025-07-16 07:31","pubTimestamp":1752622290,"startTime":"0","endTime":"0","summary":"全球超过30亿超重或肥胖人群构成的庞大市场，让GLP-1类药物成为医药行业最炙手可热的赛道。“卷”不动了GLP-1市场的“内卷”已触及天花板，市场饱和度提升与销售增速下滑的迹象日益显著。根据2025年初数据显示，目前全球处于临床试验阶段的GLP-1相关管线高达179个，仅中国申报临床的GLP-1类新药就已超过了50个。GLP-1从来不缺乏争议，但争议的焦点早已从“谁能颠覆胰岛素”变成了“谁还能留在牌桌”。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716074053a6ac01cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716074053a6ac01cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1571399168.USD","IE00BFTCPJ56.SGD","LU1057294990.SGD","IE00B4R5TH58.HKD","IE00B2B36J28.USD","NVO","LU0289739699.SGD","LU0058720904.USD","MRK","LU1061106388.HKD","GLP","LU0320765992.SGD","LU0868494617.USD","BK4585","LU0109394709.USD","BK4534","BK4533","LU2468319806.SGD","LU1983299246.USD","LU0122379950.USD","LU2242646821.SGD","BK4581","IE0002141913.USD","LU0889565916.HKD","LU2112291526.USD","SG9999001440.SGD","LU2242652126.USD","BK4590","LU1023059063.AUD","BK4599","LLY","LU2089984988.USD","BK4566","BK4588","IE00BJJMRZ35.SGD","BK4144","BK4139","AMGN","IE0009355771.USD","IE00BJT1NW94.SGD"],"gpt_icon":1},{"id":"2551191379","title":"诺和诺德等公司中标杨凌示范区医院耗材遴选项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2551191379","media":"DoNews","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551191379?lang=zh_cn&edition=full","pubTime":"2025-07-16 02:07","pubTimestamp":1752602822,"startTime":"0","endTime":"0","summary":"天眼查App显示，2025年7月14日，杨凌示范区医院发布内分泌代谢性疾病科耗材遴选结果公告。该项目遴选结果涉及多个品类的耗材，中标供应商包括诺和诺德（中国）制药有限公司、通化东宝药业股份有限公司、深圳硅基传感科技有限公司、苏州海神联合医疗器械有限公司、北京华益精点生物技术有限公司、微泰医疗器械（杭州）、北京迈世通科技、陕西扩甲实业有限公司、陕西致远创新科贸有限公司和陕西松天信息技术有限公司。本次公告类型为中标结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071602081897a7593c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071602081897a7593c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","600867","NVO","LU1093756325.SGD","LU1093756168.USD","BK4585","IE00BKVL7J92.USD","BK4007","BK4599","LU0154236417.USD","IE00BZ1G4Q59.USD","BK4532"],"gpt_icon":0},{"id":"2551193805","title":"美国OTC市场Novo Nordisk A/S盘中异动 股价大涨3.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551193805","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551193805?lang=zh_cn&edition=full","pubTime":"2025-07-15 22:06","pubTimestamp":1752588364,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日22时06分，美国OTC市场Novo Nordisk A/S股票出现异动，股价快速拉升3.08%。截至发稿，该股报69.08美元/股，成交量159股，换手率0.00%，振幅2.35%。美国OTC市场Novo Nordisk A/S股票所在的制药行业中，整体涨幅为0.05%。美国OTC市场Novo Nordisk A/S公司简介：诺和诺德拥有全球约三分之一的品牌糖尿病治疗市场，是全球领先的糖尿病护理产品供应商。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071522060595439177&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071522060595439177&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","NONOF","IE00BKVL7J92.USD","LU1093756168.USD","BK4599","BK4588","BK4007","BK4532","LU1093756325.SGD","LU0154236417.USD","IE00BZ1G4Q59.USD","NVO"],"gpt_icon":1},{"id":"2551153995","title":"诺和诺德7月14日成交额为4.15亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551153995","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551153995?lang=zh_cn&edition=full","pubTime":"2025-07-15 12:30","pubTimestamp":1752553855,"startTime":"0","endTime":"0","summary":"美东时间2025年7月14日，诺和诺德成交额为4.15亿美元，成交额较昨日减少7.74%，当日成交量为601.59万股。诺和诺德于2025年7月14日涨0.01%，报68.94美元，该股过去5个交易日跌0.55%，年初至今跌18.78%，过去60日涨6.9%。诺和诺德还有一个生物制药部门，专门从事血友病和其他疾病的蛋白质疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715123100a44b6391&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715123100a44b6391&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4599","NVO","LU1093756168.USD","IE00BKVL7J92.USD","BK4588","IE00BZ1G4Q59.USD","LU1093756325.SGD","BK4532","LU0154236417.USD","BK4007"],"gpt_icon":1},{"id":"2551917925","title":"礼来长效减肥疗法再获批准上市；诺和诺德再递交司美格鲁肽监管申请 TIDES周报","url":"https://stock-news.laohu8.com/highlight/detail?id=2551917925","media":"动脉网","labels":["productRelease","policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551917925?lang=zh_cn&edition=full","pubTime":"2025-07-13 07:31","pubTimestamp":1752363060,"startTime":"0","endTime":"0","summary":"礼来长效减肥疗法在加拿大获批，诺和诺德向EMA提交司美格鲁肽新剂量申请，健康元获腾盛博药独家许可研究新型抗菌脂肽。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071309371995406cd2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071309371995406cd2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1868836914.USD","LU1093756168.USD","SG9999014880.SGD","LU2417539215.USD","LU0471298777.SGD","SGXZ81514606.USD","LU0471298694.HKD","LU0320765059.SGD","LU2357305700.SGD","LU2491050071.SGD","LLY","LU1023059063.AUD","IE0002141913.USD","IE00B1BXHZ80.USD","LU0323591593.USD","IE00BK4W5M84.HKD","LU1093756325.SGD","LU2361044949.HKD","NVO","IE00B2B36J28.USD","LU0889565916.HKD","SG9999014898.SGD","SG9999014914.USD","SG9999015986.USD","SG9999015945.SGD","BK4585","LU0198837287.USD","LU2361044865.SGD","LU1291159041.SGD","LU1064131342.USD","LU0823416689.USD","LU1069344957.HKD","LU0354030438.USD","LU1868836591.USD","LU0097036916.USD","LU0256863902.USD","LU0096364046.USD","LU1127390331.HKD","LU1035775433.USD","LU0882574055.USD","LU2089984988.USD","LU0820561818.USD","BK4532","LU1814569148.SGD","LU1989771016.USD","LU0316494557.USD","LU1868837300.USD","LU2361045086.USD","LU0238689110.USD","LU0385154629.USD"],"gpt_icon":0},{"id":"2550957803","title":"美股异动 | 医药板块走低 诺和诺德(NVO.US)跌超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550957803","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550957803?lang=zh_cn&edition=full","pubTime":"2025-07-11 23:21","pubTimestamp":1752247279,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周五，美股医药板块走低，未能延续本周涨势。截至发稿，诺和诺德(NVO.US)跌超3%，Moderna(MRNA.US)跌超2.4%，礼来(LLY.US)跌超1%，辉瑞(PFE.US)跌近1%。消息面上，据报道，FDA可能会加快药物审评以降低美国药品价格。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f0eae99d4bb3c0558aa729c90596db1e","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1317015.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","IE00BZ1G4Q59.USD","BK4599","BK1161","LU1093756168.USD","NVO","LU0154236417.USD","BK4007","BK1574","09939","BK4585","159938","IE00BKVL7J92.USD","LU1093756325.SGD","BK1515","BK4532"],"gpt_icon":0},{"id":"2550600379","title":"诺和诺德7月10日成交额为4.53亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550600379","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550600379?lang=zh_cn&edition=full","pubTime":"2025-07-11 12:33","pubTimestamp":1752208412,"startTime":"0","endTime":"0","summary":"美东时间2025年7月10日，诺和诺德成交额为4.53亿美元，成交额较昨日增加21.08%，当日成交量为637.83万股。诺和诺德于2025年7月10日涨1.89%，报71.01美元，该股过去5个交易日涨1.7%，年初至今跌16.34%，过去60日涨9.7%。诺和诺德还有一个生物制药部门，专门从事血友病和其他疾病的蛋白质疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711123333a443ed26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711123333a443ed26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","IE00BKVL7J92.USD","BK4599","BK4585","BK4588","LU1093756325.SGD","LU0154236417.USD","IE00BZ1G4Q59.USD","LU1093756168.USD","BK4532","NVO"],"gpt_icon":1},{"id":"2550262419","title":"美国OTC市场Novo Nordisk A/S盘中异动 早盘股价大涨3.32%报72.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550262419","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550262419?lang=zh_cn&edition=full","pubTime":"2025-07-10 23:26","pubTimestamp":1752161205,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日23时26分，美国OTC市场Novo Nordisk A/S股票出现波动，股价大幅上涨3.32%。截至发稿，该股报72.14美元/股，成交量869股，换手率0.00%，振幅5.21%。美国OTC市场Novo Nordisk A/S股票所在的制药行业中，整体涨幅为0.92%。美国OTC市场Novo Nordisk A/S公司简介：诺和诺德拥有全球约三分之一的品牌糖尿病治疗市场，是全球领先的糖尿病护理产品供应商。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071023264697a11f4e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071023264697a11f4e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","NVO","LU1093756325.SGD","LU1093756168.USD","BK4585","IE00BKVL7J92.USD","BK4007","BK4599","LU0154236417.USD","IE00BZ1G4Q59.USD","NONOF","BK4532"],"gpt_icon":1},{"id":"2550949956","title":"诺和诺德7月9日成交额为3.74亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550949956","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550949956?lang=zh_cn&edition=full","pubTime":"2025-07-10 12:31","pubTimestamp":1752121862,"startTime":"0","endTime":"0","summary":"美东时间2025年7月9日，诺和诺德成交额为3.74亿美元，成交额较昨日减少45.70%，当日成交量为538.00万股。诺和诺德于2025年7月9日涨0.07%，报69.69美元，该股过去5个交易日跌0.19%，年初至今跌17.89%，过去60日涨13.85%。诺和诺德还有一个生物制药部门，专门从事血友病和其他疾病的蛋白质疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710123107a6a0c28b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710123107a6a0c28b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LU1093756325.SGD","BK4532","BK4599","LU0154236417.USD","BK4588","BK4585","LU1093756168.USD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","NVO"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.novonordisk.com","stockEarnings":[{"period":"1week","weight":-0.0065},{"period":"1month","weight":-0.0948},{"period":"3month","weight":0.0894},{"period":"6month","weight":-0.1766},{"period":"1year","weight":-0.4986},{"period":"ytd","weight":-0.2237}],"compareEarnings":[{"period":"1week","weight":0.0108},{"period":"1month","weight":0.0582},{"period":"3month","weight":0.1745},{"period":"6month","weight":0.0313},{"period":"1year","weight":0.1338},{"period":"ytd","weight":0.073}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Novo Nordisk A/S成立于1989年，由两家丹麦公司Nordisk Gentofte A/S和Novo Industri A/S合并而成。该公司是一家全球医疗保健公司，也是糖尿病和肥胖症护理领域的全球领导者。该公司拥有广泛的糖尿病和肥胖症护理以及罕见疾病产品组合，包括用于治疗糖尿病和肥胖症的胰高血糖素样肽-1(GLP-1)受体激动剂、现代胰岛素和人胰岛素。","yearOnYearQuotes":[{"month":1,"riseRate":0.522727,"avgChangeRate":0.119015},{"month":2,"riseRate":0.613636,"avgChangeRate":0.028062},{"month":3,"riseRate":0.454545,"avgChangeRate":0.006986},{"month":4,"riseRate":0.613636,"avgChangeRate":0.01505},{"month":5,"riseRate":0.555556,"avgChangeRate":0.018382},{"month":6,"riseRate":0.688889,"avgChangeRate":0.026171},{"month":7,"riseRate":0.488889,"avgChangeRate":0.004654},{"month":8,"riseRate":0.522727,"avgChangeRate":0.001751},{"month":9,"riseRate":0.568182,"avgChangeRate":-0.002657},{"month":10,"riseRate":0.5,"avgChangeRate":-0.002241},{"month":11,"riseRate":0.613636,"avgChangeRate":0.027229},{"month":12,"riseRate":0.727273,"avgChangeRate":0.04916}],"exchange":"NYSE","name":"诺和诺德","nameEN":"Novo-Nordisk A/S"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"诺和诺德(NVO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供诺和诺德(NVO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"诺和诺德,NVO,诺和诺德股票,诺和诺德股票老虎,诺和诺德股票老虎国际,诺和诺德行情,诺和诺德股票行情,诺和诺德股价,诺和诺德股市,诺和诺德股票价格,诺和诺德股票交易,诺和诺德股票购买,诺和诺德股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"诺和诺德(NVO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供诺和诺德(NVO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}